SCHEMBL5742829

SCHEMBL5742829

COc1cc2c(cc1OC)C(CCc1ccc(F)c(C(F)(F)F)c1)NCC2

nearest known ligand 0.56

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
BCHE P06276 1/20 0.53
KDM4C Q9H3R0 1/20 0.51
KMT2A Q03164 2/20 0.50
MEN1 O00255 1/20 0.50
GRIN2D O15399 4/20 0.46
GRIN3B O60391 4/20 0.46
GRIN1 Q05586 4/20 0.46
GRIN2A Q12879 4/20 0.46
GRIN2B Q13224 4/20 0.46
GRIN2C Q14957 4/20 0.46
GRIN3A Q8TCU5 4/20 0.46
KDM4E B2RXH2 1/20 0.46
MAPT P10636 1/20 0.46
PKM P14618 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4026394 1.00 BCHE (0.53) BCHEKDM4CKMT2AMEN1GRIN2D
SCHEMBL4023796 0.92 BCHE (0.53) BCHEKDM4CKMT2AMEN1KDM4E
SCHEMBL4028072 0.89 BCHE (0.52) BCHEKDM4CKMT2AGRIN2DGRIN3B
SCHEMBL4025481 0.88 BCHE (0.58) BCHEKDM4CKMT2AMEN1GRIN2D
SCHEMBL4027325 0.86 BCHE (0.56) BCHEKDM4CKMT2AMEN1GRIN2D
SCHEMBL990798 0.85 BCHE (0.57) BCHEKDM4CKMT2AKDM4EMAPT
SCHEMBL1680336 0.85 BCHE (0.57) BCHEKDM4CKMT2AKDM4EMAPT
SCHEMBL3346743 0.85 BCHE (0.57) BCHEKDM4CKMT2AKDM4EMAPT
SCHEMBL4027162 0.84 BCHE (0.64) BCHEKDM4CKMT2AMEN1KDM4E
SCHEMBL4030199 0.84 BCHE (0.56) BCHEKDM4CKMT2AMEN1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1611104-A1 TETRAHYDROISOQUINOLYL ACETAMIDE DERIVATIVES FOR USE AS OREXIN RECEPTOR ANTAGONISTS Actelion Pharmaceuticals Ltd. (CH) 2006-01-04 EP disclosed
WO-2004085403-A1 TETRAHYDROISOQUINOLYL ACETAMIDE DERIVATIVES FOR USE AS OREXIN RECEPTOR ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2004-10-07 WO disclosed